000 01548 a2200421 4500
005 20250512053901.0
264 0 _c19870109
008 198701s 0 0 eng d
022 _a0317-1671
024 7 _a10.1017/s0317167100036672
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBonnet, A M
245 0 0 _aA controlled study of oral vigabatrin (gamma-vinyl GABA) in patients with cerebellar ataxia.
_h[electronic resource]
260 _bThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
_cNov 1986
300 _a331-3 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAminocaproates
_xadverse effects
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Evaluation
650 0 4 _aFriedreich Ataxia
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeurologic Examination
650 0 4 _aOlivopontocerebellar Atrophies
_xdrug therapy
650 0 4 _aRandom Allocation
650 0 4 _aSpinocerebellar Degenerations
_xdrug therapy
650 0 4 _aVigabatrin
700 1 _aEsteguy, M
700 1 _aTell, G
700 1 _aSchechter, P J
700 1 _aHardenberg, J
700 1 _aAgid, Y
773 0 _tThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
_gvol. 13
_gno. 4
_gp. 331-3
856 4 0 _uhttps://doi.org/10.1017/s0317167100036672
_zAvailable from publisher's website
999 _c3471154
_d3471154